nature.com search

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature

Search
My Account Login

nature
search

Search

advanced

where the list of authors contains where the title contains

Refine your results by…

volume

start page / article no.

Filters

Filter By:

Article type

Check one or more article types to show results from those article types only.

Research (3)

Journal

Check one or more journals to show results from those journals only.

British Journal of Cancer (2)
Cell Death & Disease (1)

Choose more journals

Subject Check one or more subjects to show results from those subjects only.

Cancer (2)
Cell biology (1)
Immunology (1)
Medical research (1)
Pathogenesis (1)
Diseases (1)
Health care (1)

Date

Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
In the last year
Last 2 years
Last 5 years

Custom date range

Sort by Relevance

Choose a way to sort results.

Relevance
Date — most recent
Date — oldest first

Loading Filters

Showing 1–3 of 3 results

Loading Filters

Research | 23 July 2013 | Open
Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
- daniel.palmer@liverpool.ac.uk
- D H Palmer
- , S A Hussain
- , A J Smith
- , S Hargreaves
- , Y T Ma
- , D Hull
- , P J Johnson
- & P J Ross
British Journal of Cancer 109 , 888–890

Rights & permissionsfor article Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom . Opens in a new window.
Research | 22 March 2018 | Open
A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma
- Daniel.Palmer@liverpool.ac.uk
- D. H. Palmer
- , Y. T. Ma
- , M. Peck-Radosavljevic
- , P. Ross
- , J. Graham
- , L. Fartoux
- , A. Deptala
- , M. Studeny
- , D. Schnell
- , J. Hocke
- , A-B. Loembé
- & T. Meyer
British Journal of Cancer 118 , 1162–1168

Rights & permissionsfor article A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma . Opens in a new window.
Research | 8 May 2014 | Open
Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-κB activation via a negative feedback loop
- Daniel.Palmer@liverpool.ac.uk
- T Elmetwali
- , L S Young
- & D H Palmer
Cell Death & Disease 5 , e1213–e1213

Rights & permissionsfor article Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-<i>κ</i>B activation via a negative feedback loop . Opens in a new window.

Advertisement

Search

Search articles by keyword or author

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

nature.com sitemap

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
Nano
Protocol Exchange
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Nature Research Academies

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Career development

Nature Careers
Nature Conferences
Nature events

Regional websites

Nature China
Nature India
Nature Japan
Nature Korea
Nature Middle East

Legal & Privacy

Privacy Policy
Use of cookies
Manage cookies/Do not sell my data
Legal notice
Accessibility statement
Terms & Conditions
California Privacy Statement

© 2021 Springer Nature Limited